Networks of Centres of Excellence of Canada
Government of Canada

Common menu bar links

Centre for Surgical Invention and Innovation - CSii

$14.8 million for 2009-17
About   |   News   |   Features   |   Videos
Centre for Surgical Invention and Innovation

Number of partners
16

Partner contributions
$28.4 million

Headquarters
Hamilton, Ontario

Scientific Director and CEO
Mehran Anvari Mehran Anvari

Board chair
Douglas Barber Douglas Barber
Professor in Residence, McMaster University

Applying Canada's expertise in space robotics to medicine


The opportunity

When it comes to space robotics, Canada is an undisputed global leader. The industry has invested more than $2 billion in research and development for more than 30 years, overcoming many of the hurdles associated with automation, image guidance and manoeuvrability. On the medical front, several Canadian universities are top ranked when it comes to developing image-guided therapies. These strengths put Canada in an excellent position to use its expertise to make the medical system more efficient, improve healthcare access in rural and remote areas, and improve patient outcomes by enabling more targeted, less invasive procedures.

How CSii is seizing the opportunity

The Centre for Surgical Invention and Innovation (CSii) combines the skills and know-how of academic staff and practising clinicians with private sector business acumen to develop and commercialize a new class of advanced image-guided robotic systems that will extend the diagnostic and interventional capabilities of surgeons, physicians and health care professionals through increased precision and dexterity. CSii partners with MacDonald, Dettwiler and Associates Ltd. (MDA), the world leader in space robotics and developer of the famous Canadarm, to test, prototype, validate and commercialize new technologies that can dramatically improve surgical results, and reduce the trauma and recovery times for patients.

Among the results

  • CSii completed development of its Image Guided Automated Robot (IGAR), a generic image-guided robotics platform that will be adopted for several applications, including biopsies and localized cancer treatment. The system can also be operated remotely, enabling radiologists to biopsy and treat patients in remote locations.
  • CSii successfully developed and manufactured its first clinical system – the IGAR Breast Robot – which allows real-time biopsy and therapy of suspected breast lesions in an MRI system, resulting in less pain and faster treatment. CSii is partnering with MDA to manufacture the system in Canada, and has initiated a startup for global sales and distribution. Commercial release is planned for 2017.
  • CSii is working with IBM’s Watson Collaborative Group and the Canadian Space Agency (CSA) to develop the next generation of IGAR: an autonomous robotic system capable of diagnosing, planning and executing medical diagnostic and therapeutic actions. CSii is also working with the CSA to develop telerobotic capabilities for IGAR technology that will improve access to health care for Canadians living in remote parts of the country.

Connect with CSii

 

Features
Space-age robot making cancer biopsies more accurate
February 10, 2015
Women from Ontario and Quebec will continue to be among the world’s first to have a breast biopsy taken by a robotic surgeon that can trace its technological pedigree to the Canadarm and International Space Station. The made-in-Canada technology promises to be less time consuming and more accurate than current manual procedures and can be operated by a radiologist remotely, ensuring equal access to surgical care across all of Canada. Read more
Videos
Watch Video
Canadian Space technology helps breast cancer patients
October 1, 2014